An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. (Record no. 10435097)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01490 a2200421 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250513192112.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199909s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0006-4971 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Silver, R T |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19990929 |
| 245 00 - TITLE STATEMENT | |
| Title | An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Blood |
| Date of publication, distribution, etc. | Sep 1999 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1517-36 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bone Marrow Transplantation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Busulfan |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Combined Modality Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Evidence-Based Medicine |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hydroxyurea |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
| General subdivision | therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transplantation, Homologous |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Woolf, S H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hehlmann, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Appelbaum, F R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Anderson, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bennett, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Goldman, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guilhot, F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kantarjian, H M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lichtin, A E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Talpaz, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tura, S |
| 773 0# - HOST ITEM ENTRY | |
| Title | Blood |
| Related parts | vol. 94 |
| -- | no. 5 |
| -- | p. 1517-36 |
No items available.